iBio is a United States-based biotechnology company with a focus on streamlining the process of making a pharmaceutical product available on the market. It has developed platforms and has manufacturing facilities in Texas which can develop and product medical solutions such as vaccines, biotherapeutics, diagnostic products, and some medical devices.
COVID-19
The company's platform called FastPharming uses technology to expedite the development process for making medical solutions, such as the one necessary for COVID-19 due to the pandemic is has caused. iBio partnered with the Infectious Disease Research Institute (IDRI) to develop a vaccine where the company is set to provide process development and manufacturing services to IDRI, which is in charge of the pre-clinical development of the vaccine and clinical studies overview.
Timeline
Funding rounds
People
Tom Isett
CEO
Further reading
IBio Expands COVID-19 Vaccine Collaboration - Contract Pharma
Web
iBio Joins the Alliance for Biosecurity
Web
March 20, 2020
Documentaries, videos and podcasts
Companies
References
Company attributes
Categories
Related Topics
Contributors
- 1
Jessica Karpinski
I'm a knowledge seeker with a thirst to understand how the world is connected. - 2
Julius John Villarisco
Every day is a new learning for me, new opportunity every time. Never limit my self, think outside the box. - 3
Erin Scherfner
Golden Research Assistant - 4
Aleksander Holm
Interested in understanding the world we live in.